Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$92.27 - $101.54 $2,214 - $2,436
24 Added 6.22%
410 $41,000
Q3 2023

Nov 01, 2023

BUY
$94.73 - $105.13 $3,410 - $3,784
36 Added 10.29%
386 $39,000
Q4 2021

Jan 31, 2022

SELL
$79.7 - $88.13 $35,865 - $39,658
-450 Reduced 56.25%
350 $31,000
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $4.92 Million - $5.81 Million
-58,966 Reduced 98.66%
800 $68,000
Q4 2020

Jan 29, 2021

SELL
$78.07 - $94.43 $86,033 - $104,061
-1,102 Reduced 1.81%
59,766 $5.64 Million
Q3 2020

Oct 28, 2020

BUY
$82.14 - $91.0 $52,733 - $58,422
642 Added 1.07%
60,868 $5.29 Million
Q2 2020

Jul 27, 2020

BUY
$80.93 - $91.1 $326,147 - $367,133
4,030 Added 7.17%
60,226 $5.26 Million
Q1 2020

May 07, 2020

BUY
$70.67 - $99.01 $61,836 - $86,633
875 Added 1.58%
56,196 $4.63 Million
Q4 2019

Feb 04, 2020

SELL
$84.35 - $95.37 $91,941 - $103,953
-1,090 Reduced 1.93%
55,321 $5.24 Million
Q3 2019

Nov 04, 2019

SELL
$85.54 - $94.26 $4.79 Million - $5.28 Million
-56,006 Closed
0 $0
Q2 2019

Jul 18, 2019

SELL
$75.4 - $92.8 $11,310 - $13,920
-150 Reduced 0.27%
56,006 $5.11 Million
Q1 2019

Apr 29, 2019

SELL
$75.32 - $86.15 $17,850 - $20,417
-237 Reduced 0.42%
56,156 $5.4 Million
Q4 2018

Jan 17, 2019

SELL
$73.66 - $82.02 $962,736 - $1.07 Million
-13,070 Reduced 18.82%
56,393 $4.84 Million
Q3 2018

Oct 25, 2018

BUY
$66.94 - $77.43 $233,620 - $270,230
3,490 Added 5.29%
69,463 $5.99 Million
Q2 2018

Jul 19, 2018

SELL
$64.91 - $73.36 $58,419 - $66,024
-900 Reduced 1.35%
65,973 $4.98 Million
Q1 2018

Apr 27, 2018

BUY
$70.39 - $84.15 $184,773 - $220,893
2,625 Added 4.09%
66,873 $5.41 Million
Q4 2017

Feb 05, 2018

SELL
$72.33 - $77.64 $62,203 - $66,770
-860 Reduced 1.32%
64,248 $5.39 Million
Q3 2017

Oct 27, 2017

BUY
$74.14 - $77.27 $4.83 Million - $5.03 Million
65,108
65,108 $5.59 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bourgeon Capital Management LLC Portfolio

Follow Bourgeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.